What's Happening?
U.S. Customs and Border Protection (CBP) has issued an interim final rule that significantly alters the requirements for who can act as a U.S. Importer of Record (IOR) and when foreign IORs must utilize
a Customs Trade Partnership Against Terrorism (C-TPAT) validated customs broker. Effective January 5, 2027, a company will only qualify as a U.S. IOR if it is organized under U.S. law, located in the United States, and either has at least 51% qualifying U.S. citizen or lawful permanent resident beneficial owners who control it, or directly owns a substantial amount of unencumbered U.S. real property. A U.S. subsidiary or address alone will no longer suffice for U.S. IOR status. Foreign IORs that are not C-TPAT validated will be required to designate a licensed, C-TPAT validated customs broker for covered entries. These changes apply to both formal and informal entries filed on CBP Forms 3461 or 7501. CBP's motivation behind these stricter rules is to enhance customs enforcement and ensure accountability, addressing concerns about difficulties in collecting unpaid duties and enforcing laws when importers' assets are outside the U.S.
Why It's Important?
This new rule carries significant implications for foreign companies importing goods into the United States. Businesses that previously operated as U.S. IORs based on less stringent criteria may now be reclassified as foreign IORs, necessitating immediate adjustments to their import processes. The mandate for C-TPAT validation, either directly or through a customs broker, introduces an additional layer of compliance and cost. Companies not already C-TPAT validated will need to either undergo the validation process, which can be time-consuming, or secure the services of a C-TPAT validated broker. This could lead to increased operational expenses and potential delays if not addressed proactively. The rule also places a greater burden on customs brokers, who must now request and review supporting records to verify a client's IOR status, potentially leading to more rigorous vetting processes and rejected entries if documentation is insufficient. The overall aim is to provide CBP with greater visibility into importers and their supply chains, which could lead to more efficient enforcement but also increased scrutiny for importers.
What's Next?
Foreign companies importing into the U.S. must immediately review their current IOR status and broker arrangements to ensure compliance by the January 5, 2027, deadline. This involves classifying each IOR entity based on the new criteria, confirming that their chosen customs broker is licensed and C-TPAT validated if the IOR is foreign and not directly validated, and preparing comprehensive evidence of formation, ownership, control, and U.S. operations or property for any U.S. IOR claims. Importers should also coordinate closely with their brokers regarding required verification documents and CBP Form 5106 information. The interim final rule is open for comments until January 5, 2027, under docket USCBP-2026-1387, providing an opportunity for stakeholders to provide feedback. Failure to comply could result in entry disruptions, penalties, and other enforcement actions from CBP.
Beyond the Headlines
The new CBP rule reflects a broader trend towards enhanced supply chain security and accountability in international trade. By tightening the definition of a U.S. IOR and mandating C-TPAT involvement for foreign IORs, CBP is not only aiming to improve revenue collection and law enforcement but also to foster more secure and transparent supply chains. C-TPAT validation, which involves a rigorous assessment of a company's security measures, is designed to mitigate risks such as terrorism, smuggling, and other illicit activities. This move could encourage more foreign entities to invest in robust security protocols, thereby strengthening global supply chain resilience. However, it also raises questions about potential barriers to entry for smaller foreign businesses that may find C-TPAT validation or the cost of a C-TPAT broker prohibitive, potentially impacting market competition and the diversity of goods available in the U.S. market. The long-term implications could include a more consolidated import landscape dominated by larger, more compliant entities.












